全腺治療（根治性前列腺切除和放射治療）一直是局部前列腺癌的傳統治療，但與觀察性等待或主動監測相比，隨機對照試驗並未顯示出生存益處。全腺治療也與顯著的長期後遺症有關，包括尿失禁、勃起功能障礙、輻射性膀胱炎和直腸炎。
適應症：Prostate Cancer
收案條件
納入條件
- Patients who have undergone focal therapies for prostate cancer at the Department of Surgery, Queen Mary Hospital
- Includes but not limited to: cryotherapy, high-intensity focused ultrasound (HIFU), focal laser therapy (FLA), and irreversible electroporation (IRE)
- Willing and able to provide written informed consent
排除條件
- Patients who are incapable to provide written informed consent.
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。